E-ISSN: 2587-0831 ISSN: 2587-0831
POSTMENOPAUSAL HORMONE REPLACEMENT THERAPY; CHANGES OF THE MAMMOGRAPHIC FINDINGS
PDF
Cite
Share
Request
Research Article
VOLUME: 5 ISSUE: 1
P: 18-24
January 2009

POSTMENOPAUSAL HORMONE REPLACEMENT THERAPY; CHANGES OF THE MAMMOGRAPHIC FINDINGS

Eur J Breast Health 2009;5(1):18-24
Ayşegül Sarsılmaz 1
Pınar Balcı 2
Murat Celiloğlu 3
Sinem Karazincir 4
Makbule Varer 1
Melda Apaydın 1
1. Atatürk Eğitim ve Araştırma Hastanesi, Radyoloji Bölümü, İzmir, Türkiye
2. Dokuz Eylül Üniversitesi Tıp Fakültesi, Radyodiyagnostik Anabilim Dalı, İzmir, Türkiye
3. Dokuz Eylül Üniversitesi Tıp Fakültesi, Kadın Hastalıkları ve Doğum Anabilim Dalı, İzmir, Türkiye
4. Mustafa Kemal Üniversitesi Tayfur Ata Sökmen Tıp Fakültesi, Radyodiyagnostik Anabilim Dalı, Antakya, Türkiye
No information available.
No information available
Received Date: 15.09.2008
Accepted Date: 29.10.2008
PDF
Cite
Share
Request

ABSTRACT

Objective:

HRT is known to result mammographic alterations, especially elevating the density that decreases the sensitivity of the mammography. In this study we have aimed to display the eff ect of HRT on the mammographic fi ndings in consideration with the therapy protocols.

Material and Methods:

1025 cases who were in menopause for at least 1 year and administered HRT for at least 1 year were chosen as a study group that was compared to the control group which includes 111 cases who did not received HRT. Two consecutive mammographies were retrospectively evaluated. Densitometric measurements (quantitative method), Wolfe classifi cation fi ndings were compared between before and after HRT. The new developing lesions, alterations in the present lesions were also evaluated by dividing the cases according to protocols; continues combined, cyclic combined, estrogenconjugated estrogen, tibolone, the control group.

Results:

The most prominent increase in the density was in the continues combined group(%49,p=0.001). Estrogen therapy group was observed. Tibolone had the minimal eff ect(%28,p>0.05). The increase in the density of the tibolone group was statistically insignifi cant in all evaluations. In the control group, the alteration was towards decrease in the density (%44, p<0.0000).. In the estrogen therapy group, the development of malignant lesions was statistically signifi cant (%5, p<0.02). (2 case DCIS, 2 case IDC). In the tibolone group the regression in the lesions was signifi cant.

Conclusion:

Continues combined therapy increases the density of breast signifi - cantly, tibolone is the minimal eff ective drug. In the estrogen therapy group, the development of malign lesions after HRT was statistically signifi cant.

Keywords:
Hormone replacement therapy, mammography, breast density